Clinical Trial Update: Safety Study of PP-007 in Subjects With Acute Ischemic Stroke [Phase 1]

View source ↗

Summary

A Phase 1 safety study of PP-007 in subjects with acute ischemic stroke has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• PP-007

Snippet

Sponsor: Prolong Pharmaceuticals | Conditions: Acute Ischemic Stroke | Phase 1 | Status: COMPLETED